Warning: session_start(): open(/opt/alt/php74/var/lib/php/session/sess_e496b7e1d551be97b9b82ab38aa69bbb, O_RDWR) failed: Disk quota exceeded (122) in /home/useaicwl/public_html/wp-content/themes/mushroomstocks/functions.php on line 278

Warning: session_start(): Failed to read session data: files (path: /opt/alt/php74/var/lib/php/session) in /home/useaicwl/public_html/wp-content/themes/mushroomstocks/functions.php on line 278
This Company Has A Portfolio Of Products Positioned To Win - Mushroomstocks | Mushroomstocks
Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

This Company Has A Portfolio Of Products Positioned To Win

Aug 2, 2017 • 11:15 AM EDT
X Sprays.png
4 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Cannabis based products and extracts are a burgeoning vertical within the legal cannabis industry and we expect this segment to continue to experience above average growth for years to come.

One of the reasons we should see continued growth within the cannabis products and extracts industry is the growing trend toward smokeless products. Cannabis based products have been found to possess tremendous health benefits and this has also made such products very attractive to consumers, especially the elderly in particular. 

While marijuana cultivation and retail operations continue to attract the most investor interest, companies focused on the cannabis based products and extracts have flown under the radar.

In late July, we started to watch CNRP Mining Inc. (CND.CN) after it signed a letter of intent to acquire X-Sprays, which develops and sells a life-enhancement product administered through an optimal oral spray delivery system.

A Unique Natural Product Targeting Major Indications

X-Sprays proprietary product line is comprised of eight health care and life enhancement nutraceutical products that include both hemp CBD and nutraceutical ingredients (4 with CBD and 4 nutraceutical).

X-Sprays is targeting indications with a massive addressable market and has focused its efforts on creating a natural product line of oral sprays to deliver medicines, nutrients and vitamins. The product contains natural fruit or mint flavors and are free of: artificial flavors, artificial colors, sugar, starch, wheat, soy, gluten, eggs, salt and dairy.

X-Sprays’ product provides a precise dose and each one contains a 30-day supply when used as suggested (8 sprays every day). The company’s products include:

Focused on New and Burgeoning Opportunities

Although CBD products have generated significant consumer interest, Tetrahydrocannabinol (THC) continues to be the primary revenue driver within the cannabis industry.

X-Sprays plans to expand its product line to include THC based products and expects to see the products generate significant demand with cannabis consumers. The product line is unique when compared to others on the market and this offers the company a competitive advantage.  

One of the attractive aspects of X-Sprays fundamental story is to the minimal capital and resources needed to enter new markets. X-Sprays is implementing a multi-faceted distribution strategy and will use traditional retail outlets, its e-commerce outlet, and non-traditional retail outlets such as spas, bars, hotels, and cruises.

Market Responds Favorably, A Stock You Cannot Miss

X-Sprays is led by a management team has more than 20 years of relevant experience and has demonstrated an ability to create value for its shareholders. The management team has worked hard to get the product to where it is today and they have been seeing strong re-order numbers from its e-commerce store.

When it comes to cannabis investments, it always starts with the management team and we are favorable on X-Sprays leadership. The company is levered to a multi-billion-dollar market and offers products that are effective and stand out from the competition.

We will continue to monitor how this team continues to execute and deliver value to its shareholders. X-Sprays is a company that we will continue to monitor and believe this is stock that needs to be watched!

Reach out to Support@mushroomstocks.com for more information  


Stay up to date on the GreenRush by subscribing to Mushroomstocks… 


Important Investor Disclosures 

Paid Affilaite. This report was authored by and is property of Mushroomstocks.  All information and data relied upon in drafting this report is publicly available.  The author believes and considers its sources to be reliable, but does not guarantee the accuracy or completeness of any information contained in this report.  Any and all information, data, analyses and opinions are provided for informational purposes only and is not intended, in any manner, as investment advice.  Any projections or other information generated by Mushroomstocks regarding the likelihood of various investment outcomes are hypothetical in nature, do not reflect actual investment results, and are not guarantees of future results.  None of the material contained in this report is intended as a solution or offer to sell or purchase a specific stock or any other investment.  This report is not directed to, or intended for distribution or use by, any person or entity that is a citizen, resident or located in any municipality, state, country or other jurisdiction where the distribution, publication, availability, or use of this report is contrary to any governing law or regulation.  The securities discussed in this report may not be eligible for purchase and/or sale in certain jurisdictions or by particular individuals.  It is important that you check any and all governing laws and/or regulations that may be applicable in your jurisdiction.  Investing in securities of issuers organized outside of the United States, including ADRs, entail certain risks.  The securities of non-United States issuers may not be registered with, nor be subject to the reporting requirements of the United States Securities and Exchange Commission.  Please contact a Financial Advisor for professional advice regarding any and all securities investments.  This report is intended for informational purposes only

Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Mushroomstocks.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.

Fatal error: Uncaught ErrorException: md5_file(/home/useaicwl/public_html/wp-content/litespeed/css/f981cf32bb45aa5af1bfa55c54698c6e.css.tmp): failed to open stream: No such file or directory in /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php:126 Stack trace: #0 [internal function]: litespeed_exception_handler(2, 'md5_file(/home/...', '/home/useaicwl/...', 126, Array) #1 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php(126): md5_file('/home/useaicwl/...') #2 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(797): LiteSpeed\Optimizer->serve('https://mushroo...', 'css', true, Array) #3 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(319): LiteSpeed\Optimize->_build_hash_url(Array) #4 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(252): LiteSpeed\Optimize->_optimize() #5 /home/useaicwl/public_html/wp-includes/class-wp-hook.php(310): LiteSpeed\Optimize->f in /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php on line 126